1. Home
  2. ESPR vs CAC Comparison

ESPR vs CAC Comparison

Compare ESPR & CAC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Esperion Therapeutics Inc.

ESPR

Esperion Therapeutics Inc.

HOLD

Current Price

$3.16

Market Cap

814.3M

Sector

Health Care

ML Signal

HOLD

Logo Camden National Corporation

CAC

Camden National Corporation

HOLD

Current Price

$53.13

Market Cap

876.2M

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
ESPR
CAC
Founded
2008
1875
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Major Banks
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
814.3M
876.2M
IPO Year
2013
1996

Fundamental Metrics

Financial Performance
Metric
ESPR
CAC
Price
$3.16
$53.13
Analyst Decision
Strong Buy
Buy
Analyst Count
4
2
Target Price
$8.75
$47.00
AVG Volume (30 Days)
9.6M
86.9K
Earning Date
05-07-2026
04-28-2026
Dividend Yield
N/A
3.51%
EPS Growth
60.71
6.08
EPS
N/A
1.29
Revenue
$403,135,000.00
$41,739,000.00
Revenue This Year
N/A
$19.15
Revenue Next Year
$12.81
$6.05
P/E Ratio
N/A
$41.22
Revenue Growth
21.31
16.96
52 Week Low
$0.95
$35.00
52 Week High
$4.18
$53.71

Technical Indicators

Market Signals
Indicator
ESPR
CAC
Relative Strength Index (RSI) 67.43 62.79
Support Level $3.11 $46.61
Resistance Level $3.18 $53.64
Average True Range (ATR) 0.02 1.84
MACD -0.02 0.13
Stochastic Oscillator 62.50 89.08

Price Performance

Historical Comparison
ESPR
CAC

About ESPR Esperion Therapeutics Inc.

Esperion Therapeutics Inc is a commercial-stage biopharmaceutical company currently focused on bringing new medicines to patients that address unmet medical needs. It has developed and is commercializing U.S. Food and Drug Administration, or FDA, approved oral, once-daily, non-statin medicines for patients who are at risk for cardiovascular disease (or CVD and are struggling with elevated low-density lipoprotein cholesterol, or LDL-C. The Company views its operations and manages its business in one operating segment, which is the business of researching, developing, and commercializing therapies for the treatment of patients with elevated LDL-C. The company depends almost entirely on the success of two products, the bempedoic acid tablet and the bempedoic acid/ezetimibe combination tablet.

About CAC Camden National Corporation

Camden National Corporation is a banking solutions provider in the United States. Its core business is providing commercial banking products to individuals and corporates. Its consumer and commercial banking services entail services such as loans and deposits, savings and online banking, treasury management solutions and non-profit products to consumer, institutional, municipal, non-profit and commercial customers. The company also offers investment management and fiduciary services.

Share on Social Networks: